One-4-ALL Initiative
Launched by UNIVERSITY OF COLORADO, DENVER · Jul 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The One-4-ALL Initiative is a study focused on improving healthcare for everyone, especially those who have faced barriers to accessing care, such as racial and cultural minorities and low-income families. The goal is to enhance health outcomes, improve the experience of patients and caregivers, lower healthcare costs, and support healthcare providers. The COVID-19 pandemic highlighted the urgent need for these improvements, making this initiative even more important.
If you are a guardian of a patient or a healthcare provider, you may be eligible to participate in this study. There are no specific exclusions, so almost anyone in these roles can join. Participants can expect to engage in discussions about healthcare experiences and share insights that could help shape better care practices in the future. This study is currently recruiting, and by taking part, you can contribute to meaningful changes that aim to ensure better health for all.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All guardians of patients and the providers (surgeons, doctors, nurses, etc) that serve these patients.
- Exclusion Criteria:
- • None.
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Trial Officials
Jill Landsbaugh Kaar, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials